Products available in Hong Kong:

  • Kyprolis® (carfilzomib)

  • Neulasta® 


  • Prolia® (denosumab)

  • Repatha® (evolocumab)

  • Vectibix® (panitumumab)

  • XGEVA® (denosumab)

Medical Information

Intended for healthcare professionals, this application provides information on submitting inquiries, prescribing information and speaking directly to a medical information healthcare professional.

Global Patient Safety

Amgen is committed to patient Safety and the Global Patient Safety Department is responsible for oversight of Pharmacovigilance activity. Patient safety is our highest priority. To fulfill our commitment to patient safety, Amgen’s Global Patient Safety Team applies a comprehensive, continuous and rigorous approach to pharmacovigilance.